BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37133501)

  • 1. PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.
    Jamke M; Herber R; Haase MA; Jasper CS; Pillunat LE; Pillunat KR
    Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2901-2915. PubMed ID: 37133501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.
    Pillunat KR; Herber R; Haase MA; Jamke M; Jasper CS; Pillunat LE
    Acta Ophthalmol; 2022 May; 100(3):e779-e790. PubMed ID: 34331505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
    Baker ND; Barnebey HS; Moster MR; Stiles MC; Vold SD; Khatana AK; Flowers BE; Grover DS; Strouthidis NG; Panarelli JF;
    Ophthalmology; 2021 Dec; 128(12):1710-1721. PubMed ID: 34051211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study.
    Panarelli JF; Moster MR; Garcia-Feijoo J; Flowers BE; Baker ND; Barnebey HS; Grover DS; Khatana AK; Lee B; Nguyen T; Stiles MC; Sadruddin O; Khaw PT;
    Ophthalmology; 2024 Mar; 131(3):266-276. PubMed ID: 37769852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.
    Aghayeva FA; Chronopoulos P; Schuster AK; Pfeiffer N; Hoffmann EM
    Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3045-3053. PubMed ID: 33963917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of PreserFlo
    Quaranta L; Micheletti E; Carassa R; Bruttini C; Fausto R; Katsanos A; Riva I
    Adv Ther; 2021 Aug; 38(8):4403-4412. PubMed ID: 34251652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device-modified trabeculectomy for glaucoma.
    Park J; Rittiphairoj T; Wang X; E JY; Bicket AK
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study.
    Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M
    Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom.
    Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S
    Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Selective Laser Trabeculoplasty on Circadian Intraocular Pressure Following Trabeculectomy in Advanced Primary Open-angle Glaucoma.
    Pillunat KR; Herber R; Wolfram S; Jasper CS; Waibel S; Pillunat LE
    J Glaucoma; 2022 Feb; 31(2):96-101. PubMed ID: 34919063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study.
    Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM
    Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XEN
    Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
    Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
    Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
    Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study.
    Bhayani R; Martínez de la Casa JM; Figus M; Klabe K; Rabiolo A; Mercieca K
    Eye (Lond); 2023 Mar; 37(4):644-649. PubMed ID: 35277663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of MicroShunt implantation versus standard trabeculectomy for open-angle glaucoma (a SIGHT study): study protocol of a multicentre randomised controlled trial.
    Scheres LMJ; van den Biggelaar FJHM; Winkens B; Kujovic-Aleksov S; Müskens RPHM; de Waard PWT; de Crom RMPC; Ernest PJG; Pijl BJ; Ramdas WD; van Rijn LJ; Tan A; Dirksen CD; Beckers HJM
    BMC Ophthalmol; 2023 Jan; 23(1):43. PubMed ID: 36721130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma.
    Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Bechrakis N; Kohlhaas M
    J Curr Ophthalmol; 2022; 34(2):180-186. PubMed ID: 36147269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: A registry study.
    Bøhler AD; Traustadóttir VD; Hagem AM; Tønset TS; Drolsum L; Kristianslund O
    Acta Ophthalmol; 2024 Mar; 102(2):186-191. PubMed ID: 37340695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of selective laser trabeculoplasty on lowering intraocular pressure fluctuations and nocturnal peak intraocular pressure in treated primary open-angle glaucoma patients.
    Pillunat KR; Kocket GA; Herber R; Jasper CS; Lenk J; Pillunat LE
    Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1979-1985. PubMed ID: 36418515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention.
    Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK
    Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PreserFlo™ MicroShunt Versus Ab Externo Canaloplasty in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Retrospective Study.
    Habbe KJ; Kohlhaas M; Fili S
    Cureus; 2023 Feb; 15(2):e35185. PubMed ID: 36960244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.